TY - JOUR
T1 - Chloride imbalance is involved in the pathogenesis of optic neuritis in neuromyelitis optica
AU - Akaishi, Tetsuya
AU - Takahashi, Toshiyuki
AU - Himori, Noriko
AU - Takeshita, Takayuki
AU - Nakazawa, Toru
AU - Aoki, Masashi
AU - Nakashima, Ichiro
N1 - Funding Information:
Ichiro Nakashima – Received Funding for a Trip and Speaks from Biogen Japan, Mitsubishi Tanabe Pharma, Novartis Pharma, Takeda Pharmaceutical Company. Served as an editorial board member of Multiple Sclerosis International. Received grant support from LSI Medience Corporation.
Publisher Copyright:
© 2018 Elsevier B.V.
PY - 2018/7/15
Y1 - 2018/7/15
N2 - Chloride imbalance between the serum and the cerebrospinal fluid (CSF) has been recently shown to exist in the acute phase of neuromyelitis optica (NMO). In this report, we studied the relation between the quotient of chloride (QCl) and the severity of optic neuritis (ON) in NMO patients. There was a positive correlation (R = 0.67; p < 0.05) between QCl and the length of ON-lesion. The visual prognosis also showed a positive correlation with QCl in the acute phase (R = 0.58; p < 0.05). These results support the theory that chloride imbalance between serum and CSF may trigger the ON in NMO spectrum disorders.
AB - Chloride imbalance between the serum and the cerebrospinal fluid (CSF) has been recently shown to exist in the acute phase of neuromyelitis optica (NMO). In this report, we studied the relation between the quotient of chloride (QCl) and the severity of optic neuritis (ON) in NMO patients. There was a positive correlation (R = 0.67; p < 0.05) between QCl and the length of ON-lesion. The visual prognosis also showed a positive correlation with QCl in the acute phase (R = 0.58; p < 0.05). These results support the theory that chloride imbalance between serum and CSF may trigger the ON in NMO spectrum disorders.
KW - Chloride imbalance
KW - Neuromyelitis optica
KW - Optic neuritis
KW - Quotient of chloride
KW - Visual prognosis
UR - http://www.scopus.com/inward/record.url?scp=85044100478&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044100478&partnerID=8YFLogxK
U2 - 10.1016/j.jneuroim.2018.03.010
DO - 10.1016/j.jneuroim.2018.03.010
M3 - Article
C2 - 29572032
AN - SCOPUS:85044100478
SN - 0165-5728
VL - 320
SP - 98
EP - 100
JO - Journal of Neuroimmunology
JF - Journal of Neuroimmunology
ER -